Visitor Monitoring Drug History: CAMPTOSAR
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: CAMPTOSAR
FDA Application No: (NDA) 020571
Active Ingredient(s): IRINOTECAN HYDROCHLORIDE
Company: PHARMACIA AND UPJOHN
 
Label History
 
View the label approved on August 4, 2006 for CAMPTOSAR, (NDA) 020571


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
8/1/2006 030Labeling Revision Letter
Label 
7/21/2005 028Labeling Revision Letter
Label 
7/21/2005 027Labeling Revision Letter
Label 
6/7/2005 026Labeling Revision Letter
Label 
7/21/2005 024Labeling Revision Letter
Label 
12/3/2004 023Labeling Revision Letter
Label 
6/24/2004 021Efficacy Supplement with Clinical Data to Support Letter
Label
Review 
7/30/2002 017Manufacturing Change or Addition  
5/16/2002 016Labeling Revision Letter
Label 
11/5/2001 014Control Supplement  
8/6/2001 013Control Supplement  
7/29/2000 011Manufacturing Change or Addition  
4/20/2000 009New or Modified Indication Letter
Label
Review 
10/22/1998 008Accelerated Approval Letter
Label
Review 
3/18/1998 007Labeling Revision Review 
1/15/1998 006Formulation Revision Review 
10/21/1997 005Control Supplement  
3/7/1997 004Labeling Revision  
6/5/1997 003Package Change  
12/10/1997 002Control Supplement  
1/3/1997 001Labeling Revision  
6/14/1996 000Approval Label 
 
©2019 Drugs That Causes a False Positive on a Drug Test